DPI-386

DPI-386 · Repurposed Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DPI-386, covering 2023-03-21 to 2023-03-21. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of DPI-386 Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion [Phase 3]

See pricing